Editorial 2. Risks and benefits of long-term intrathecal analgesia

Anaesthesia

Volumn 59, Issue 7, 2004, Pages 633-635

  Dickson, Diana ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; BACLOFEN; BUPIVACAINE; CLONIDINE; CORTICOSTEROID; GROWTH HORMONE; MORPHINE; OPIATE; SEX HORMONE; NARCOTIC ANALGESIC AGENT;

CANCER PAIN; CATHETER INFECTION; CEREBROSPINAL FLUID; CHRONIC GRANULOMATOUS DISEASE; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; ENDOCRINE DISEASE; EPIDURAL ANESTHESIA; GRANULOMA; HORMONE RELEASE; HUMAN; INFUSION PUMP; INTRACTABLE PAIN; LOW DRUG DOSE; MYELOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN SATURATION; PAIN ASSESSMENT; PATIENT MONITORING; POSTOPERATIVE ANALGESIA; QUALITY OF LIFE; RESPIRATION DEPRESSION; RISK BENEFIT ANALYSIS; SIDE EFFECT; SPASTICITY; SPINAL CORD COMPRESSION; DRUG DELIVERY SYSTEM; INTRASPINAL DRUG ADMINISTRATION; RISK ASSESSMENT;

ANALGESICS, OPIOID; DRUG DELIVERY SYSTEMS; HUMANS; INJECTIONS, SPINAL; PAIN, INTRACTABLE; RISK ASSESSMENT;

EID: 3242882926     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2004.03871.x     Document Type: Editorial

References (14)

1. Pert CB, Snyder SH. Opiate receptor: demonstration in nervous tissue. Science 1973; 179: 1011-4.
2. Yaksh TL, Rudy TA. Analgesia mediated by a direct spinal action of narcotics. Science 1976b; 192: 1357-8.
3. Clinical guidelines for intraspinal infusion. Report of an expert panel. Journal of Pain and Symptom Management 2000; 20: 537-43.
4. Endocrine consequences of long-term intrathecal administration of opioids. Journal of Clinical Endocrinology and Metabolism 2000; 85: 2215-22.
5. North RB, Cutchis PN, Epstein JA, Long DM. Spinal cord compression complicating subarachnoid infusion of morphine: Case report and laboratory experience. Neurosurgery 1991; 29: 778-84.
6. Aldrete JA, Vascello LA, Ghaly R, Tomlin D. Paraplegia in a patient with an intrathecal catheter and a spinal cord stimulator. Anaesthesiology 1994; 81: 1542-5.
7. Blount JP, Remley KB, Yue SK, Erickson DL. Intrathecal granuloma complicating chronic spinal infusion of morphine. Journal of Neurosurgery 1996; 84: 272-6.
8. Bejjani GK, Karim NO, Tzortzidis F. Intrathecal granuloma after implantation of a morphine pump. Surgical Neurology 1997; 48: 288-91.
9. Cabbell KL, Taren JA, Sagher OS. Spinal cord compression by catheter granulomas in high dose intrathecal morphine therapy: Case report. Neurosurgery 1998; 42: 1176-81.
10. Anderson SR, Orbegozo M, Racz G, Prithvi Raj P. Intrathecal granuloma in patients receiving high dose intrathecal morphine therapy: a report of two cases. Pain Practice 2001; 1: 61-7.
11. Coffey RJ, Burchiel K. Inflammatory mass lesions associated with intrathecal drug infusion catheters. Report and observations on 41 patients. Neurosurgery 2002; 50: 8-87.
12. Yaksh TL, Hassenbusch S, Burchiel K, Hildebrand KR, Page LM, Coffey RJ. Inflammatory masses associated with intrathecal drug infusion: a review of preclinical evidence and human data. Pain Medicine 2002; 3: 300-12.
13. Hassenbusch S, Burchiel K, Coffey RJ et al. Management of intrathecal catheter-tip masses: a consensus statement. Pain Medicine 2002; 3: 313-23.
14. Mehta AC, Kay EA, Overend M, Dickson DE. Stability of diamorphine for use in implantable pumps. Pharmacy in Practice, May 1997: 253-5.